Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 21
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT00349466 | Safety and Efficacy Study of CF101 to Treat Keratoconjunctivitis Sicca | ||
| NCT02647762 | CF101 Therapy Compared to Methotrexate Therapy for Active Rheumatoid Arthritis | ||
| NCT00428974 | Safety and Efficacy Study of CF101 to Treat Psoriasis | ||
| NCT00790673 | A Phase 1/2 Study of CF102 in Patients With Chronic Hepatitis C Genotype 1 | ||
| NCT06643260 | A Phase 3 Study in Moderate-to-Severe Plaque Psoriasis With Piclidenoson to Study Safety and Efficacy | ||
| NCT05201404 | Namodenoson in the Treatment of Advanced Hepatocellular Carcinoma in Patients With Child-Pugh Class B7 Cirrhosis | ||
| NCT00556894 | Oral CF101 Tablets and Methotrexate Treatment in Rheumatoid Arthritis Patients | ||
| NCT04697810 | Namodenoson in the Treatment of Non-Alcoholic Steatohepatitis (NASH) | ||
| NCT04333472 | Piclidenoson for Treatment of COVID-19 | ||
| NCT01033422 | Safety and Efficacy of Daily CF101 Administered Orally in Subjects With Elevated Intraocular Pressure | ||
| NCT00280917 | Oral CF101 and Methotrexate Treatment in Rheumatoid Arthritis Patients | ||
| NCT02128958 | Phase 2, Randomized, Double-Blind, Placebo-Controlled of the Efficacy and Safety of CF102 in Hepatocellular Carcinoma (HCC) | ||
| NCT01905124 | Safety &Efficacy of CF101 to Subjects With Uveitis | ||
| NCT01265667 | Trial of CF101 to Treat Patients With Psoriasis | ||
| NCT00837291 | A Study of the Efficacy and Safety of CF101 to Patients With Osteoarthritis of the Knee | ||
| NCT01235234 | Trial of CF101 to Treat Patients With Dry Eye Disease | ||
| NCT00790218 | A Phase 1-2 Study of CF102 in Patients With Advanced Hepatocellular Carcinoma | ||
| NCT01034306 | Oral CF101 Tablets Treatment in Patients With Rheumatoid Arthritis | ||
| NCT02927314 | A Study of the Efficacy and Safety of CF102 in the Treatment of Non-Alcoholic Fatty Liver Disease | ||
| NCT06387342 | Namodenoson Treatment of Advanced Pancreatic Cancer | ||
| NCT03168256 | CF101 Therapy in Patients With Moderate-to-severe Plaque Psoriasis |
